National leaders made me DyCM; will strengthen BJP: Laxman Savadi

Mangaluru, Jan 7: Kasturba Medical College Mangaluru, a constituent unit of Manipal Academy of Higher Education (MAHE), in association with Pai Family Endowment (in memory of Shri Suhas Gopal Pai) as its social initiative opens a newborn hearing assessment centre at Govt Lady Goshen Hospital on Tuesday.

Dr M Venkatraya Prabhu, Dean of KMC Mangaluru addressing the media persons said that the project is made possible by the generous philanthropic contribution of Mrs Anuradha (Shanthi)Gopal Pai and will be inaugurated by her in Presence of Dr H Vinod Bhat, Vice-Chancellor of MAHE.

Dr Deepak Madi, Deputy Medical Superintendent KMC Hospital Attavar explained that the facility will be managed by the departments from Audiology, ENT and Paediatrics of Kasturba Medical College, Mangaluru. The Centre aims to screen all the babies born in the hospital for hearing loss.

This is the maiden initiative of the MAHE-Pai Family endowment which has been set up to find solutions for the numerous challenges faced by the hearing handicapped in & around Dakshina Kannada district.

Mangaluru, Jan 27: No power can now stop Kashmiri Pandits from going back to Kashmir, Defence Minister Rajnath Singh said on Monday, forcefully defending the NDA government’s decision to reorganise Jammu and Kashmir and abrogating its special status under Article 370.

Addressing a massive pro-CAA, NRC rally organised by the Bharatiya Janata Party at Gold Finch city, Kuloor, on the outskirts of the city, the Defence minister also sent a strong message to Pakistan and said India will not let anyone live in peace if it is harmed.

"We will not touch anyone, but if someone bothers us, then we are not going to let them live in peace," he said.

Referring to the exodus of a large number of Kashmiri Pandits from the Valley in the late 1990s at the height of militancy, Singh said no power now can stop them from returning to their homes.

On the Citizenship Amendment Act, the minister said it is not a law to hurt the sentiments of any religion but to give relief to victims of religious persecution.

Mahatma Gandhi had told Nehru to give citizenship to minorities like Hindus and Sikhs if they come to India and Prime Minister Narendra Modi has fulfilled that vision by bringing in the law, Singh said.

On several non-BJP states refusing to implement the CAA, the defence minister said it it is a central law and everyone should follow it.

Accusing the Congress of misleading people on the issue, he said the party should not forget its duty towards the nation just because it is in opposition.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.